Psoriatic Arthritis and Infection

[1]  J. Shieh,et al.  Intestinal microbiota profiling and predicted metabolic dysregulation in psoriasis patients , 2018, Experimental dermatology.

[2]  K. Venken,et al.  The Role of the Microbiome in Gut and Joint Inflammation in Psoriatic Arthritis and Spondyloarthritis , 2018, The Journal of Rheumatology. Supplement.

[3]  D. Gladman,et al.  Th17 gene expression in psoriatic arthritis synovial fluid and peripheral blood compared to osteoarthritis and cutaneous psoriasis. , 2018, Clinical and experimental rheumatology.

[4]  T. Love,et al.  Infections and the risk of psoriatic arthritis among psoriasis patients: a systematic review , 2018, Rheumatology International.

[5]  A. Lurati,et al.  The macrophages in rheumatic diseases , 2016, Journal of inflammation research.

[6]  C. Ritchlin,et al.  Bone remodeling in psoriasis and psoriatic arthritis: an update , 2016, Current opinion in rheumatology.

[7]  James T. Elder,et al.  Genome-wide Association Analysis of Psoriatic Arthritis and Cutaneous Psoriasis Reveals Differences in Their Genetic Architecture. , 2015, American journal of human genetics.

[8]  G. Basso,et al.  Transcriptional network profile on synovial fluid T cells in psoriatic arthritis , 2015, Clinical Rheumatology.

[9]  M. Diani,et al.  T cell responses in psoriasis and psoriatic arthritis. , 2015, Autoimmunity reviews.

[10]  Julia Manasson,et al.  Decreased Bacterial Diversity Characterizes the Altered Gut Microbiota in Patients With Psoriatic Arthritis, Resembling Dysbiosis in Inflammatory Bowel Disease , 2015, Arthritis & rheumatology.

[11]  Mayte Suárez-Fariñas,et al.  Immunology of psoriasis. , 2014, Annual review of immunology.

[12]  W. Ouyang,et al.  Psoriasis-associated variant Act1 D10N with impaired regulation by Hsp90 , 2012, Nature Immunology.

[13]  W. Ouyang,et al.  Psoriasis-associated variant Act1 D10N with impaired regulation by Hsp90 , 2012, Nature immunology.

[14]  N. Romani,et al.  Changing views of the role of Langerhans cells. , 2012, The Journal of investigative dermatology.

[15]  P. V. van Riel,et al.  Macrophage dysfunction in Psoriatic Arthritis , 2011, Journal of Translational Medicine.

[16]  C. Griffiths,et al.  Evidence for the presence of bacteria in the blood of psoriasis patients , 2010, Archives of Dermatological Research.

[17]  Luis Puig,et al.  Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions. , 2010, The Journal of investigative dermatology.

[18]  G. van Loo,et al.  The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology. , 2009, Trends in immunology.

[19]  A. Abdou,et al.  Evaluation of survivin and NF‐κB in psoriasis, an immunohistochemical study , 2008 .

[20]  L. Espinoza,et al.  Toll-like receptor-2 expression is upregulated in antigen-presenting cells from patients with psoriatic arthritis: a pathogenic role for innate immunity? , 2007, The Journal of rheumatology.

[21]  D. Foell,et al.  Synovial histopathology of psoriatic arthritis, both oligo- and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis , 2005, Arthritis research & therapy.

[22]  S. Porcelli,et al.  Characterization of a T cell line bearing natural killer receptors and capable of creating psoriasis in a SCID mouse model system. , 2000, Journal of dermatological science.

[23]  P. Njobvu,et al.  Psoriatic arthritis and human immunodeficiency virus infection in Zambia. , 2000, The Journal of rheumatology.

[24]  F. D'armiento,et al.  Microscopic inflammatory changes in colon of patients with both active psoriasis and psoriatic arthritis without bowel symptoms. , 2000, The Journal of rheumatology.

[25]  B. Anderson,et al.  V2 regions of 16S ribosomal RNA used as a molecular marker for the species identification of streptococci in peripheral blood and synovial fluid from patients with psoriatic arthritis. , 1999, Arthritis and rheumatism.

[26]  D. Gladman.  Psoriatic arthritis: recent advances in pathogenesis and treatment. , 1992, Rheumatic diseases clinics of North America.

[27]  A. Berman,et al.  Psoriatic arthritis and acquired immunodeficiency syndrome. , 1988, Arthritis and rheumatism.

[28]  W. J. Cromartie,et al.  Effect of acetylation on arthropathic activity of group A streptococcal peptidoglycan-polysaccharide fragments , 1987, Infection and immunity.

[29]  S. Wahl,et al.  Inhibition by cyclosporin A of streptococcal cell wall-induced arthritis and hepatic granulomas in rats. , 1986, Arthritis and rheumatism.

[30]  L. Gerber,et al.  IgA-containing immune complexes in patients with psoriatic arthritis. , 1984, Clinical and experimental rheumatology.

[31]  L. Espinoza,et al.  Possible involvement of group A streptococci in the pathogenesis of psoriatic arthritis. , 1982, The Journal of rheumatology.

[32]  L. Espinoza,et al.  Vascular changes in psoriatic synovium. A light and electron microscopic study. , 1982, Arthritis and rheumatism.

[33]  H. Esseveld,et al.  A study of the incidence of haemolytic streptococci in the throat in patients with psoriasis vulgaris, with reference to their role in the pathogenesis of this disease. , 1970, Dermatologica.

[34]  A. Nørholm-Pedersen.  Infections and psoriasis; a preliminary communication. , 1952 .